Juno Therapeutics, Inc. Company Profile

06:12 EST 17th December 2018 | BioPortfolio

About Opus Bio

News Articles [709 Associated News Articles listed on BioPortfolio]

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

Nearly four years after investors snapped up new shares of Juno Therapeutics in a $265 million IPO, cancer immunotherapy remains a hot ticket. Like Juno, Allogene Therapeutics just pulled in a massive...

Juno Therapeutics And Agios: Two Really Big Fish That Got Away

As an early-stage VC, you miss some big ones. The author explores two big early stage biotech deals he missed, Agios and Juno, with some reflections on how they went down.

Juno’s Fontenot Joins Immusoft as Chief Scientific Officer

Jason Fontenot has been appointed chief scientific officer of Seattle cell therapy developer Immusoft. Fontenot most recently worked at Seattle cancer immunotherapy company Juno Therapeutics, which wa...

Effortel, een van 's werelds toonaangevende mondiale MVNE's, selecteert JUNO Software voor de ...

BOEKAREST, Roemenië, September 13, 2018 /PRNewswire/ -- Effortel, de bekroonde mondiale MVNE [Mobiele Virtuele Netwerk Enabler], heeft JUNO Software SRL gekozen om een aangepast platform Read more.....

Effortel, einer der weltweit führenden MVNEs, wählt JUNO Software für die Entwicklung von ...

BUCHAREST, Rumänien, September 13, 2018 /PRNewswire/ -- Effortel, der preisgekrönte globale MVNE, entschied sich für JUNO Software SRL zur Entwicklung und Implementierung einer maßgeschneiderten S...

#Biotech fun tidbit of the day "Our checks suggest acquirers are facing difficulty in integrating CAR-T acquisitions -- in particular $JUNO, which has been facing a culture clash with $CELG (we understand they closed the JUNO HQ internal brewery)" [via

#Biotech fun tidbit of the day "Our checks suggest acquirers are facing difficulty in integrating CAR-T acquisitions -- in particular $JUNO, which has been facing a culture clash with $CELG (we u...

ASCO 2018: will JCAR017 become the third CAR-T product for lymphoma?

Updated data from the pivotal Phase I TRANSCEND-NHL-001 trial evaluating Juno Therapeutics’ (Celgene) CAR-T candidate JCAR017 in aggressive non-Hodgkin’s lymphoma...Read More... The post ASCO 2018...

Jupiter’s magnetic field revealed by the Juno spacecraft

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

JUNO, the receptor of sperm IZUMO1, is expressed by the human oocyte and is essential for human fertilisation.

Is JUNO protein present at the surface membrane of human oocytes and involved in the fertilisation process?

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [165 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

This study will provide long-term follow-up for patients who have received treatment with a Juno CAR T-cell product in a Juno-sponsored clinical trial. In this study, patients will be foll...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1287 Associated Companies listed on BioPortfolio]

Juno Therapeutics, Inc.

About Opus Bio

Juno Online Services, Inc.

Juno is a nationwide ISP offering consumers a choice of 3 low price dial up Internet access options to meet their budget and personal Internet access needs. Juno Platinum Internet service offers a val...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Juno Therapeutics, Inc." on BioPortfolio

We have published hundreds of Juno Therapeutics, Inc. news stories on BioPortfolio along with dozens of Juno Therapeutics, Inc. Clinical Trials and PubMed Articles about Juno Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Juno Therapeutics, Inc. Companies in our database. You can also find out about relevant Juno Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record